Exelon Related Clinical Trials
A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon�) Administration in Young Healthy Male Volunteers [Not yet recruiting]
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients [Recruiting]
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence [Recruiting]
Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients [Recruiting]
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia [Recruiting]
Mild Cognitive Impairment in Parkinson's Disease [Recruiting]
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease [Recruiting]
Rivastigmine Prophylaxis in Elderly Patients Undergoing Major Surgery [Recruiting]
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment [Recruiting]
Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients [Recruiting]
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease [Recruiting]
Rivastigmine Study in Adolescents With Down Syndrome [Recruiting]
Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy [Recruiting]
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems [Recruiting]
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease [Completed]
Efficacy of Rivastigmine in Patients With Down Syndrome [Recruiting]
Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI [Not yet recruiting]
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type [Recruiting]
Rivastigmine as a Treatment for Methamphetamine Dependence [Recruiting]
Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients [Terminated]
Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine [Not yet recruiting]
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia [Recruiting]
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Completed]
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) [Recruiting]
Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors [Recruiting]
Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment [Completed]
Rivastigmine Capsules in Patients With Probable Vascular Dementia [Completed]
Safety and Tolerability of Long-Term Treatment by Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Enrolling by invitation]
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. [Recruiting]
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Recruiting]
RIVastigmine In Vascular cognitivE Impairment [Completed]
Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease [Recruiting]
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-Daily 10 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) [Recruiting]
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease [Completed]
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment [Terminated]
An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits [Completed]
Long-Term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-Severe Dementia Associated With Parkinson's Disease (PDD) [Recruiting]
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Recruiting]
Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study [Recruiting]
Rivastigmine in Mild Alzheimer's Disease, FMRI Study [Active, not recruiting]
Rivastigmine for Intensive Care Unit (ICU) Delirium [Recruiting]
Rivastigmine in the Management of Delirium [Recruiting]
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia [Completed]
Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) [Completed]
Cognitive Decline in Non-demented PD [Recruiting]
MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Donepezil or Rivastigmine Therapy [Recruiting]
Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery [Completed]
Rivastigmine For Methamphetamine Dependent Individuals [Not yet recruiting]
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Completed]
An Open-Label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Completed]
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline [Recruiting]
Comparative Research of Alzheimer's Disease Drugs [Recruiting]
Treatment of Orthostatic Hypotension in Autonomic Failure [Recruiting]
Neuromodulation and Language Acquisition (Stage Ib) [Suspended]
Neuromodulation and Language Acquisition (Project Stage Ia) [Terminated]
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease [Recruiting]
Electrophysiologic Measures of Treatment Response in Alzheimer Disease [Completed]
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease [Completed]
Safety and Cognitive Function Study of EVP-6124 in Patients With Alzheimer's Disease [Recruiting]
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Completed]
Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Terminated]
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease [Completed]
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease [Recruiting]
Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction [Recruiting]
Cilostazol Augmentation Study in Dementia [Recruiting]
Enhancing Motor Task Training by Action Observation Watching Others Perform the Task [Recruiting]
Clinical Trial of Donepezil Between the Naive Group and the Switching Group [Recruiting]
|
